2nd patient with stable disease, page-106

Something was niggling at me so I did some more revision. (I bought more yesterday. Always expected a pullback from 4c). Anyway this bit after Cohort1 results intrigued me. Remember these unfortunates are the ones who didn't respond to conventional drugs. Plus they received very little PAT-SM6.

"Post inclusion to the trial, two out of the three patients went on to receive additional chemotherapy due to advancing disease. Both patients had a unexpectedly positive response to drugs they had previously been resistant to." See more at:

http://imagesignal.comsec.com.au/docserver/01389460.pdf?fileid=01389460&datedir=20130307&edt=MjAxMy0wOC0wNyswNzo1MzozNisxMjArMCtjb21zZWMrcmVkaXJlY3QrL2ltYWdlc2lnbmFsL2Vycm9ycGFnZXMvUERGVGltZW91dC5odG1sKy9pbWFnZXNpZ25hbC9lcnJvcnBhZ2VzL3BkZmRlbGF5ZWQuanNw

So in the last few months with only minimal dosage of PAT-SM6 and dealing amongst the most infective patients, 2 out of eight patients have had direct positive response and two others were helped indirectly. Looking forward to Cohort4 and beyond.

It would be wonderful for mankind if these natural antibodies do indeed work as hoped. Gives investing added feelings of goodwill.